At a glance
What is it—and why does it matter?
Sigumir is described as a polypeptide complex obtained from cartilage and bone tissues of young animals.
Sources for this introduction: [1]
This published profile is a reference in progress. Findings retain their source context; missing topics are marked below.
What is it?
A molecule, not a product name.
Identity
The source characterizes Sigumir as a peptide bioregulator intended for cartilaginous and bone tissues.
1 cited source · Study independence not established
How to read this evidence
Sources and study IDs describe provenance, not clinical strength. Several articles can report the same study; one study can support several distinct findings. No clinical strength rating has been assigned here.
1 cited passage across 1 source record. 1 publication group(s) lack a resolved study identity.
Evidence boundary: Applies only to the source-defined population, formulation, dose, and assessment period.
Exact passages, locators, and provenance
- supports · Source-backed record
“use a peptide bioregulator of cartilaginous and bone tissues "Sigumir"”
[Application of bioregulating therapy in complex treatment of temporomandibular joint diseases in people of elderly and senile age]. · Abstract
pubmed:22708467:4a7c7a99463a:4a7c7a99463a
Identity
Sigumir is described as a polypeptide complex obtained from cartilage and bone tissues of young animals.
1 cited source · Study independence not established
How to read this evidence
Sources and study IDs describe provenance, not clinical strength. Several articles can report the same study; one study can support several distinct findings. No clinical strength rating has been assigned here.
1 cited passage across 1 source record. 1 publication group(s) lack a resolved study identity.
Evidence boundary: Applies only to the source-defined population, formulation, dose, and assessment period.
Exact passages, locators, and provenance
- supports · Source-backed record
“Sigumir, a polypeptide complex of cartilage and bone tissues of young animals”
[Chondrocytes secretory phenotype associated with aging: role in the pathogenesis of osteoarthritis and prospects for peptide bioregulation.]. · Abstract
pubmed:37782637:4fcfdfa4f2eb:4fcfdfa4f2eb
How does it work?
Target, response, and disposition.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
What has been studied?
What the evidence says.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
Risks and interactions
Risks, organized for scanning.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
Products and regulatory status
Same ingredient. Different records.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
Administration context
The practical clinical context.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
Research status + gaps
What still needs better answers?
- No publishable claim yet for: administration, contraindication, effect, interaction, mechanism, regulatory, safety
- 9 compiled claim(s) withheld by automated assurance: assurance_score_below_0.58 (7), current_regulatory_source_required (1), extraction_ambiguity (7), high_risk_requires_regulatory_or_two_independent_sources (2), no_direct_support (7)
These are the limits of this profile, not an exhaustive list of scientific uncertainties.
References + discovery
Open the records yourself.
- [Application of bioregulating therapy in complex treatment of temporomandibular joint diseases in people of elderly and senile age]. ↗
pubmed · published 2012-01-01 · retrieved 2026-09-04T22:24:51Z
- [Chondrocytes secretory phenotype associated with aging: role in the pathogenesis of osteoarthritis and prospects for peptide bioregulation.]. ↗
pubmed · published 2023-01-01 · retrieved 2026-09-04T22:24:51Z
Publication history and provenance
Version 2 · Automated assessment · 2026-09-04T22:24:51Z
fdf68647546ced38ba9815a4828bd6a9144a3e4b5b4cb3a26549110b2f68bdec